Objective: To evaluate the anti-microsporidial effects of the active component of Nigella sativa seeds, thymoquinone, against Encephalitozoon intestinalis using an in vitro model.
Introduction
Microsporidia are obligate intracellular, spore-forming parasites that infect both vertebrates and invertebrates. There are 14 microsporidia species that cause infection in humans. Encephalitozoon spp. and Enterocytozoon bieneusi are considered to be the clinically important pathogens and cause opportunistic infection in immunocompromised individuals [1] [2] [3] .
Treatment of microsporidia infections is not easy since they are intracellular parasites and have natural resistance from a spore wall.
Albendazole and fumagillin are the two most widely used drugs in the treatment of microsporidiosis since they are more effective than other alternative therapeutic agents and less toxic to living cells [4, 5] .
Albendazole binds to tubulin and inhibits the polymerization of tubulin to microtubules. It remains the drug of choice in treatment although it does not have desirable activity against some microsporidians and in some cases, recurrences are reported [6] . Fumagillin is effective in the treatment of Enterocytozoon bieneusi infections in AIDS patients, so, its use is limited to people with HIV in some countries and has been associated with undesirable effects such as thrombocytopenia and neutropenia [7, 8] .
Nigella sativa (N. sativa), grown in the Eastern Europe, Middle East, and Western and Central Asia, is used to treat numbers of conditions and diseases such as eczema, asthma, diabetes, hypertension, inflammation, bronchitis, cough, fever, headache, influenza, and dizziness [9, 10] . Thymoquinone is an active compound extracted from N. sativa essential oil [11] , and has been shown to have anti-bacterial [12] , anti-fungal [13] , and anti-viral [14] characteristics in various studies. Its anti-parasitic activity has been also investigated against many parasites [15] [16] [17] [18] . However, there is no information about the effectiveness of thymoquinone against Encephalitozoon intestinalis (E. intestinalis) or any other microsporidia.
The aim of this study was to investigate whether the active component of N. sativa seeds, thymoquinone, has any antimicrosporidial effects against E. intestinalis using an in vitro model.
Materials and methods

Parasite strain and in vitro infection
The E. intestinalis reference strain (50506) was obtained from the American Type Culture Collection (ATCC). The parasites were cultured in HEK293 cells (human kidney epithelial cells, ATCC) as previously reported [19] . for 20 min at 37 曟 . The absorbance was measured at 560 nm using a microplate reader (Promega Multireader, Glomax, USA).
Chemicals
Effects of thymoquinone on the life cycle of E. intestinalis
To evaluate the inhibitory effects of thymoquinone on the life cycle of E. intestinalis, HEK293 cells were used as a host cell. HEK293 cells were cultivated in a 6-well tissue culture plate and incubated at 37 曟 in 5% CO 2 overnight. After removal of non-adherent cells, E. intestinalis spores were added and incubated at 37 曟 in 5% was considered statistically significant.
Results
Cytotoxic effect of thymoquinone on HEK293 cells
The cytotoxic effect of thymoquinone on HEK293 cell line was observed at 30, 35, and 40 µM concentrations of thymoquinone after 24, 48, and 72 hours of incubation period. Compared to the control group, DMSO, or thymoquinone at the concentration less than 30 µM did not have significant effect on cell viability (P>0.05) ( Figure   1 ).
Effects of thymoquinone on life cycle of E. intestinalis
As shown in Figure 2 , serial dilutions were appropriate to determine the density of the parasites. After 10 d, the experiments were terminated and the parasite load was assessed by quantitative real time PCR.
It was observed that 10, 15, 20, and 30 µM concentrations of thymoquinone decreased the spore density compared with the control (Figure 3) ; however, it was significant only at 30 µM (P<0.05) (Figure 3 ). The effect of 30 µM thymoquinone was similar to 8 ng/mL albendazole (P>0.05). 
Discussion
Albendazole is the most effective drug in the treatment of microsporidia to date. Recent studies have reported that this drug limits the parasite burden, however, fails in clearance of microsporidia especially in immunosuppressed individuals and can result in the reoccurrence of the disease after the treatment [21, 22] . Fumagillin is reported to be effective in the treatment of Enterocytozoon bieneusi but has some side effects [7, 8] . Some medications such as azithromycin, metronidazole, paromomycin, nitazoxanide, and cyclosporine have been used in treatment, but no effective results have been obtained [22, 23] .
Plant extracts and compounds have been used as a valuable
natural resource of traditional remedies for centuries. In previous studies, it was reported that thymoquinone shows an anti-parasitic effect against some parasites. In one study [18] , it was reported that thymoquinone showed anti-leishmanial activity (Leishmania infantum, IC 50 : 1.47 mg/mL and Leishmania tropica, IC 50 : 1.16 mg/ mL) on promastigotes after 72 hours of incubation period. In the same study, it was observed that the parasites had less macrophage invasion ability and intracellular survival rate of intramacrophage amastigotes (Leishmania infantum, IC 50 : 2.6 mg/mL and Leishmania tropica, IC 50 : 2.1 mg/mL) in the presence of thymoquinone.
Thymoquinone showed an inhibitory effect on Babesia and
Theileria proliferation in both in vitro and in vivo. These results make thymoquinone a promising candidate for use in therapy.
Other authors reported IC 50 values of thymoquinone were (0.28 ± 0.016), ( [24] . In addition,
Mahmoudvand et al. [17] revealed that thymoquinone can be a new scolicidal agent for use in hydatid cyst surgery. They reported that all of the protoscoleces died after exposure at the concentration of 1 mg/mL at 10 min. In this study, the anti-microsporidial effect of thymoquinone was evaluated for the first time. It was found that 30 µM thymoquinone inhibited the life cycle of E. intestinalis.
In addition, the amount of spores was significantly decreased ten days later. In this study, unlike against leishmania [18] , the lower concentrations of thymoquinone (30 µM for intracellular forms) were found to be more toxic for intracellular forms than extracellular spores. This can be explained by the spore structure of the parasite. While microsporidian parasites have highly resistant spores, they do not have a wall structure in its intracellular forms. It should be noted that these are the main limitations in the present study. Despite these limitations, this study gives a general idea of the use of thymoquinone. 
